GSK-2981278

DB16319InvestigationalSmall molecule

GSK-2981278 is under investigation in clinical trial NCT03004846 (A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis).

Chemical structure of GSK-2981278
Formula / weight
C25H35NO5S · 461.62 g/mol (avg)
Also known as
Ror gama modulator 1
Code names
GSK-2981278

Resolves to

Compound
UNIIL49V5G013ICAS1474110-21-8ChEMBLCHEMBL4225088
Structure
InChIKeyLZLBRISQTJVZNP-UHFFFAOYSA-NSMILESCCC1=CC=C(C=C1)N(CC(C)C)S(=O)(=O)C1=CC(CO)=C(OCC2CCOCC2)C=C1
Targets
P51449RORC

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GSK-2981278, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In